News | November 12, 2021
Solara Active Pharma Sciences PAT slides to Rs 29.71 cr in Q2FY22
Solara Active Pharma Sciences has reported consolidated financial results for the period ended September 30, 2021.
Solara Active Pharma Sciences has reported consolidated financial results for the period ended September 30, 2021.
LSDCheck is CE-IVD approved LCMSMS-based testing kit for LSD in newborns
It was recognized for its holistic initiatives designed to improve the quality of life and standards of care for patients
The solution helps the pharma enterprises drive efficiencies, save costs, and increase productivity
Venus Remedies has reported consolidated financial results for the period ended September 30, 2021
This is the eighth Covid-19 vaccine to receive Emergency Use Listing
The collaboration provides KardiaMobile users quick access to doctors worldwide for consultations about their ECG readings
It is the first integrated digital PCR solution ideal for oncology, cell and gene therapy development
Dr Lal PathLabs revenue contribution from west India to go up from 10% to 24% post-acquisition basis FY21
Subscribe To Our Newsletter & Stay Updated
